Carlos Beltran is back from the disabled list after missing the past three weeks with bone spurs in his right elbow and to make room for his return the Yankees designated infielder Scott Sizemore for assignment.
Beltran was off to a slow start before being shut down in mid-May, hitting just .234 with five homers and a .715 OPS in 33 games.
He’s returning now without having undergone surgery to remove the bone spurs from his elbow, which means Beltran could have further issues with the injury and eventually deciding on surgery remains a possibility. Not a great situation for a 37-year-old in the first season of a three-year, $45 million contract.
The Angels signed Japanese superstar Shohei Ohtani for a $2.3 million signing bonus last weekend. They may have damaged goods on their hands. Jeff Passan of Yahoo Sports reports that Ohtani underwent a physical that revealed a first-degree sprain of his ulnar collateral ligament. As a result, he got a platelet-rich plasma injection on October 20. This was made known to teams after Ohtani entered MLB’s posting system, so it wasn’t like the Angels went into this blind.
Ohtani’s report said, “Although partial damage of UCL in deep layer of his right UCL exists, he is able to continue full baseball participation with sufficient elbow care program.” It also said Ohtani “will most likely be available to start his throwing program approximately a month from the PRP.”
Passan notes that the report also mentioned that a “small free body” floats in Ohtani’s elbow near his UCL.
Ohtani isn’t without other injuries. He battled hamstring and ankle issues throughout 2017 and underwent right ankle surgery back in October. Thankfully for the Angels, this diagnosis is about as good as it could be considering the circumstances. However, if Ohtani does exacerbate his UCL issue, he may ultimately need Tommy John surgery at some point, which would take him out of action for at least a year.